Connor, Clark & Lunn Investment Management (CC&L)’s Guardant Health GH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.3M	Sell	215,395 -39,393	-15%	-$4.28M	0.06%	275
2026 Q1	$23.5M	Sell	254,788 -11,704	-4%	-$1.18M	0.05%	287
2025 Q4	$27.2M	Buy	266,492 +121,132	+83%	+$10.8M	0.07%	231
2025 Q3	$9.08M	Buy	+145,360	New	+$7.91M	0.03%	433
2023 Q3	–	Sell	-11,493	Closed	-$411K	–	1419
2023 Q2	$411K	Sell	11,493 -150,820	-93%	-$4.33M	﹤0.01%	1037
2023 Q1	$3.8M	Buy	162,313 +145,415	+861%	+$4.15M	0.02%	419
2022 Q4	$460K	Buy	+16,898	New	+$773K	﹤0.01%	883
2021 Q4	–	Sell	-3,249	Closed	-$406K	–	1123
2021 Q3	$406K	Sell	3,249 -26,373	-89%	-$3.13M	﹤0.01%	808
2021 Q2	$3.68M	Buy	29,622 +23,250	+365%	+$3.13M	0.02%	424
2021 Q1	$973K	Buy	+6,372	New	+$963K	0.01%	701

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s GH Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Guardant Health (GH) stake by 15% in Q2 2026, selling an estimated $4.28M and leaving 215,395 shares worth $32.3M. The position accounts for 0.06% of the portfolio, ranked #275.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GH in Q1 2021 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 215,395 shares of Guardant Health worth $32.3M as of Q2 2026.
Connor, Clark & Lunn Investment Management (CC&L) sold 39,393 Guardant Health shares in Q2 2026, an estimated $4.28M.
Guardant Health made up 0.06% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #275 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Guardant Health in Q1 2021 and has held it in 10 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.